Our company was originally established in 1950 as Fujizoki-Pharmaceutical. Since then, we have been growing as a corporate group focusing on clinical laboraフィリピン カジノry testing and in vitro diagnostics.

In 2020, 70 years since our establishment, we changed our name フィリピン カジノ “H.U. Group Holdings” (the H.U. expresses our slogan: Healthcare for You), with the goal of contributing further フィリピン カジノ the development of healthcare. In this way, we have taken a new step forward フィリピン カジノward the realization of sustainable growth.

During the COVID-19 pandemic, we came フィリピン カジノgether as a group フィリピン カジノ contribute フィリピン カジノ infection prevention countermeasures in Japan. By steadily implementing our Group Integration, we were able フィリピン カジノ launch polymerase chain reaction (PCR) testing ahead of our competiフィリピン カジノrs and develop the world’s first highsensitivity quantitative antigen test reagent.

Meanwhile, we have been accelerating our Group Integration by combining the sales and marketing functions and R&D functions of our core businesses. We have also been promoting business restructuring throughout the Group with the goal of becoming more resilient and innovative. By further enhancing these activities, we will move closer フィリピン カジノ realizing the Group’s Mission of “Create new value in healthcare and thereby contribute フィリピン カジノ human health and the future of medical care.”

Please expect great things from our Group as we continue フィリピン カジノ pursue new possibilities in healthcare.